New: NCI-funded clinical trial search
Mednet Logo
SpecialtiesHospital Medicine
Hospital Medicine

Hospital Medicine

Physician discussions on inpatient care, transitions of care, diagnostic reasoning, and hospital-based protocols.

Recent Discussions

What is your approach to initial assessment of disease extent in patients with Behcet's disease?

1 Answers

Mednet Member
Mednet Member
Rheumatology · NYU Grossman School of Medicine

As Behcet's syndrome is a clinical diagnosis, the symptoms that a patient presents with dictates the initial assessment, for the most part. A lot of work up is needed to rule out other conditions that may mimic Behcet's syndrome, however, assuming that has been done, evaluation for eye involvement b...

How important do you feel HLAB51 testing is in diagnosing Behcet's disease?

1 Answers

Mednet Member
Mednet Member
Rheumatology · NYU Grossman School of Medicine

The diagnosis of Behcet syndrome is based on clinical signs and symptoms. Laboratory testing and imaging studies are usually used to rule out conditions that may mimic Behcet rather than confirm the diagnosis. There is a strong genetic association between HLA-B51 and Behcet. About 50–80% of Behcet p...

What is your first treatment of choice in patients with dermatomyositis sine myositis?

1
1 Answers

Mednet Member
Mednet Member
Rheumatology · Emory University

Great question! For better or worse, there isn't a great one-size-fits-all answer since choosing the "best" agent means assessing the severity of the disease, assessing if there are extracutaneous manifestations that also need to be addressed (e.g., interstitial lung disease? inflammatory arthritis?...

Do you avoid intra-articular and bursa/tendon sheath corticosteroid injections in patients with a history of avascular necrosis?

1
2 Answers

Mednet Member
Mednet Member
Rheumatology · UC Davis

I would give intra-articular or bursa injections of steroids/glucocorticoids in patients with either active ON or a history of GC induced ON. I do not believe the local injection will increase the risk of progression or incident ON, as long as it is not given more often than every 3-4 months.

Should the age at which patients transition from pediatric to adult care differ depending on the disease diagnosis?

2 Answers

Mednet Member
Mednet Member
Rheumatology · University of Utah and Primary Children’s Hospital

First, a distinction needs to be made between transition (which is a long-term, ongoing process) and transfer of care (which is the act of going to one provider to another). Transition introduction should start early, with recommendations that age 12 is a good beginning to introduce the concepts of ...

How would you manage a patient with morbid obesity who presents with new symptomatic pulmonary embolism a few days after he was started on DOAC for DVT?

4
5 Answers

Mednet Member
Mednet Member
Medical Oncology · Ohio State University

There are guidelines from the American Society of Hematology and The International Society of Hemostasis and Thrombosis as well as expert opinions recommending either apixaban or rivaroxaban for venous thromboembolism or pulmonary embolism in patients with BMI >40. In addition, this includes use as ...

Do you use amyloid lowering therapy in patients on chronic anticoagulation?

1 Answers

Mednet Member
Mednet Member
Neurology · University of Minnesota

I wouldn’t feel comfortable doing this because of the elevated risk of ARIA-H. The Alzheimer’s Association Therapeutics Work Group advised that patients receiving anticoagulants should not be offered lecanemab (Cummings et al., PMID 37357276).

For patient with polycystic kidney disease and proteinuria who are on maximum dose of ACEi/ARB, what are other anti-proteinuric medications that should be considered?

1 Answers

Mednet Member
Mednet Member
Nephrology · UCSF

This is a great question because it highlights that patients with ADPKD should have proteinuria worked up as with any other patient with CKD - sometimes even by biopsy if needed (if tissue can be obtained safely, usually requiring urology and possibly using laparoscopic approach if ultrasound is not...

Do you recommend plasmapheresis for treatment of patients with osmotic demyelination?

1
1 Answers

Mednet Member
Mednet Member
Nephrology · UCLA

No. There are insufficient data to routinely recommend plasmapheresis for the treatment of ODS at this time. Current evidence is based predominantly on case series. In the absence of a control group, it is difficult to assess the effectiveness of plasmapheresis in the treatment of ODS.

What is your approach to establishing a dry weight in a pregnant patient with ESKD on hemodialysis given the expectation of weight increase and pregnancy-related edema?

2 Answers

Mednet Member
Mednet Member
Nephrology · Ohio State Department Of Nephrology

I think there is a lot of nuance managing weight in pregnant patients with ESRD. Pregnant patients have better fetal and maternal outcomes when clearance is increased. Outcomes are best with >36 hours of dialysis per week. Adjustment of dry weight should include assessment of volume status, blood pr...